INTRODUCTION
Infectious bronchitis disease is the prototype of Coronaviridae, acute respiratory and contagious disease in the chicken Saif et al., (1) . IB disease is characterized by respiratory signs of gasping, coughing, sneezing, tracheal rales and nasal secretions. While in young chicken's characterized by severe respiratory distress, either in laying hens are signs of respiratory distress and record a drop in egg production with loss of internal and shell quality of eggs (2) . There are many strains of IBV have a high affinity for kidney infection (Nephropathogenic strains) and accompanied by a high rate of mortality in infected birds (3) .IB disease outbreak could occur in vaccinated flocks as a result of the loss of cross-protection against antigens unrelated serotypes and variant strains of the virus (4) . A recent study by Gelb et al., (5) , proved that there is a significant immunological differences between strains and this explains the lack of cross-protection between IBV strains. In other studies proved that some vaccines as possible to stimulate protection against some field IBV infection (6) . Some researches pointed that occurs in function of genetic diversity of variant strains origin (7) . Many investigations reported to why the vaccination programs inefficiency to antigenic diversity of different IB strains because of possession of this disease on the genetic recombination phenomenon or the ability of the virus to cause mutation and generate new strains (8) . Emerged and spread variant IBV strains from vaccinated flocks despite the use of many strains of IBV as live attenuated vaccines (9) . Real time polymerase chain reaction RT-PCR assay is rapid and sensitive test was used method for the detection of nucleic acid and used widely in the detection of pathogens and quantification copy number of nucleic acid and analysis of gene expression (10) . Therefore, the protection offered by IBV strains vaccines against IBV field isolates must be evaluation. The main purpose of serotyping of IBV strains is to determine the prevalence the field IBV strains and compared with IBV strains used in the vaccination programs accordingly, the heterologous protection can break the protection resulting from the vaccine, and this is what makes it difficult to establish effective control of vaccination.The aim of this study was to determine the effectiveness of live vaccines for various IBV strains of commercial vaccines (Vovac®, Poulvac® and Avipro®) after which it is evaluating the immune response after vaccination and protection arising after the challenge. to measure the antibodies titre against the IB disease by HI according to (11) .
MATERIALS AND METHODS
Challenge birds were monitored daily for 10 days after challenge, to record the morbidity (respiratory and neurological signs) as well as the mortality rate.
RNA isolation and Real Time RT-qPCR:
The total RNA oftracheal, kidney tissue and fecal samples after 2 and day post challenge at 28 days old were extracted withTRIZOL Reagent ® (Invitrogen, USA) and then cDNAswere obtained in the RT with a Superscript III Kit(Invitrogen, USA), as described previously. The Cdnasamples were submitted to real time quantitive PCR forthe absolute quantification of viral load, and thistechnique was conducted as recommended Okinoet al. (12) , except that the primers described by Wang andTsai (6) were used in place of HV+ and HV-primers. A linear regression was determined plotting the logarithmic values of the number of copy of plasmid DNA containing the insert of gene S1 against the cycle in other organs.threshold (Ct) values, in order to convert the Ct valuesfrom tissue samples into S1 gene copy number (12) .
Challenge test:
Virulent local IBV strain (Variant2) used in the challenge in titration (100 ELD 50 daily for 10 days after challenge, to monitor the morbidity (respiratory and neurological symptoms) and mortality rate.
Statistical Analysis:
To illustrate the effect of different factors in the parameter of study used SAS system (14) . To learn significant comparison between the means in this study used least significant difference (LSD) in multiple ranges.
RESULTS

Immunity against IB by HI test
This study aimed to evaluate the efficiency of the commercial IB vaccines with the best vaccination program gives the highest protection post challenge with virulent field IBV isolate (Variant2). (Table. 1) showed birds vaccinated with different types of IB commercial vaccines induced high levels of antibodies titre.At one day old, non significant difference (P>0.05) among Ab titer of groups A, B, C, D and E (Table 1) .
It indicates correct randomization of experimental birds in the five groups. At day (7, 
DISCUSSION
In the current study, evaluating the efficiency of different commercial IB vaccines after challenge virulent field IBV (Variant2)strain. Used in this study three parameters to assess the resulting protection after challenge represented by clinical protection depending on the morbidity and mortality rate, and immune protection through determined the antibodietitres for each antigen from vaccinal strains using HI test and viral protection in the trachea, kidney and feces as sites for the IBV replication. Increase HI antibody at day (7, 14 and 21) returns to the immune generated response after vaccination, these finding agreed with Nakamura et al., (15) strategy of IBV to escape from mechanical defense of the host (25) . In addition to the less virus shedding in the environment, the vaccinated birds against IBV able to resist the challenge, which requires large amounts of the virus to become infected birds (26 
